EpiDisease's Grant

EpiDisease raised a round of funding on July 25, 2018. Investors include Fundacion Botin.

EpiDisease is a provider of biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs, thus encouraging translational research and improving the health and welfar…

Articles about EpiDisease's Grant: